ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CALT Calliditas Therapeutics AB

38.78
0.00 (0.00%)
Pre Market
Last Updated: 10:01:24
Delayed by 15 minutes
Name Symbol Market Type
Calliditas Therapeutics AB NASDAQ:CALT NASDAQ Depository Receipt
  Price Change % Change Price Bid Price Offer Price High Price Low Price Open Price Traded Last Trade
  0.00 0.00% 38.78 38.93 39.99 31 10:01:24

Invitation to the presentation of Calliditas´s interim report January - June 2024

05/08/2024 6:19am

PR Newswire (US)


Calliditas Therapeutics AB (NASDAQ:CALT)
Intraday Stock Chart


Monday 5 August 2024

Click Here for more Calliditas Therapeutics AB Charts.

STOCKHOLM, Aug. 5, 2024 /PRNewswire/ -- Calliditas's interim report for the second quarter, April - June 2024 will be published in Swedish and English on Tuesday 13 August 2024 at 07.00 a.m. CET.

A combined audio cast and telephone conference with the opportunity to ask questions will be held at 14.30 p.m. CET on the same day, with CEO Renée Aguiar-Lucander and CFO Fredrik Johansson, CMO Richard Philipson and President North America Maria Törnsén.

The presentation will be given in English.

Link to the webcast: 

https://ir.financialhearings.com/calliditas-therapeutics-q2-report-2024

To participate via conference call please register via this link:

https://conference.financialhearings.com/teleconference/?id=50049712

After registration, you will receive a phone number and a conference ID to log in to the conference call. Via the telephone conference, there is an opportunity to ask oral questions.

For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact persons set out above, on August 5, 2024 at 7:00 a.m. CET.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/calliditas-therapeutics/r/invitation-to-the-presentation-of-calliditas-s-interim-report-january---june-2024,c4019260

The following files are available for download:

https://mb.cision.com/Main/16574/4019260/2928380.pdf

Invitation to the presentation of Calliditas_Q2 2024 ENG

 

Cision View original content:https://www.prnewswire.com/news-releases/invitation-to-the-presentation-of-calliditass-interim-report-january--june-2024-302214085.html

SOURCE Calliditas Therapeutics

Copyright 2024 PR Newswire

1 Year Calliditas Therapeutics AB Chart

1 Year Calliditas Therapeutics AB Chart

1 Month Calliditas Therapeutics AB Chart

1 Month Calliditas Therapeutics AB Chart

Your Recent History

Delayed Upgrade Clock